Evasion of apoptosis as a cellular stress response in cancer

International Journal of Cell Biology

Volumn , Issue , 2010, Pages

  Fulda, Simone ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2;

APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CELLULAR STRESS RESPONSE; DRUG RESISTANCE; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 77955933845     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2010/370835     Document Type: Review

References (66)

1. Lockshin R. A., Zakeri Z., Cell death in health and disease Journal of Cellular and Molecular Medicine 2007 11 6 1214 1224
2. Kltz D., Molecular and evolutionary basis of the cellular stress response Annual Review of Physiology 2005 67 225 257
3. Fulda S., Debatin K.-M., Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy Oncogene 2006 25 34 4798 4811
4. Hengartner M. O., The biochemistry of apoptosis Nature 2000 407 6805 770 776
5. Degterev A., Boyce M., Yuan J., A decade of caspases Oncogene 2003 22 53 8543 8567
6. Kischkel F. C., Hellbardt S., Behrmann I., Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor The EMBO Journal 1995 14 22 5579 5588
7. Ashkenazi A., Targeting the extrinsic apoptosis pathway in cancer Cytokine and Growth Factor Reviews 2008 19 3-4 325 331
8. Adams J. M., Cory S., The Bcl-2 apoptotic switch in cancer development and therapy Oncogene 2007 26 9 1324 1337
9. Kroemer G., Galluzzi L., Brenner C., Mitochondrial membrane permeabilization in cell death Physiological Reviews 2007 87 1 99 163 (Pubitemid 46209992)
10. LaCasse E. C., Mahoney D. J., Cheung H. H., Plenchette S., Baird S., Korneluk R. G., IAP-targeted therapies for cancer Oncogene 2008 27 48 6252 6275
11. Fulda S., Debatin K.-M., Apoptosis signaling pathways in anticancer therapy Current Cancer Therapy Reviews 2008 4 1 14 20
12. Roos W. P., Kaina B., DNA damage-induced cell death by apoptosis Trends in Molecular Medicine 2006 12 9 440 450
13. Perkins N. D., Gilmore T. D., Good cop, bad cop: the different faces of NF- B Cell Death and Differentiation 2006 13 5 759 772
14. Weston C. R., Davis R. J., The JNK signal transduction pathway Current Opinion in Cell Biology 2007 19 2 142 149
15. Loesch M., Chen G., The p38 MAPK stress pathway as a tumor suppressor or more? Frontiers in Bioscience 2008 13 9 3581 3593
16. Okada H., Mak T. W., Pathways of apoptotic and non-apoptotic death in tumour cells Nature Reviews Cancer 2004 4 8 592 603
17. Kondo Y., Kanzawa T., Sawaya R., Kondo S., The role of autophagy in cancer development and response to therapy Nature Reviews Cancer 2005 5 9 726 734
18. Fulda S., Tumor resistance to apoptosis International Journal of Cancer 2009 124 3 511 515
19. Lavrik I., Golks A., Krammer P. H., Death receptor signaling Journal of Cell Science 2005 118 2 265 267
20. Friesen C., Fulda S., Debatin K.-M., Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells Leukemia 1997 11 11 1833 1841
21. Fulda S., Los M., Friesen C., Debatin K.-M., Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system International Journal of Cancer 1998 76 1 105 114
22. Jin Z., McDonald E. R. III, Dicker D. T., El-Deiry W. S., Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis The Journal of Biological Chemistry 2004 279 34 35829 35839
23. Petak I., Danam R. P., Tillman D. M., Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma Cell Death and Differentiation 2003 10 2 211 217
24. Van Noesel M. M., Van Bezouw S., Salomons G. S., Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation Cancer Research 2002 62 7 2157 2161
25. Pitti R. M., Marsters S. A., Lawrence D. A., Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 1998 396 6712 699 703
26. Roth W., Isenmann S., Nakamura M., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis Cancer Research 2001 61 6 2759 2765
27. Sheikh M. S., Huang Y., Fernandez-Salas E. A., The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract Oncogene 1999 18 28 4153 4159
28. Micheau O., Cellular FLICE-inhibitory protein: an attractive therapeutic target? Expert Opinion on Therapeutic Targets 2003 7 4 559 573
29. Barnhart B. C., Lee J. C., Alappat E. C., Peter M. E., The death effector domain protein family Oncogene 2003 22 53 8634 8644
30. Wang X., Wang Y., Kim H. P., Choi A. M. K., Ryter S. W., FLIP inhibits endothelial cell apoptosis during hyperoxia by suppressing Bax Free Radical Biology and Medicine 2007 42 10 1599 1609
31. Kim H. S., Lee J. W., Soung Y. H., Inactivating mutations of caspase-8 gene in colorectal carcinomas Gastroenterology 2003 125 3 708 715
32. Mandruzzato S., Brasseur F., Andry G., Boon T., Van der Bruggen P., A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma Journal of Experimental Medicine 1997 186 5 785 793
33. Teitz T., Wei W., Valentine M. B., Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nature Medicine 2000 6 5 529 535
34. Miller M. A., Karacay B., Zhu X., ODorisio M. S., Sandler A. D., Caspase 8L, a novel inhibitory isoform of caspase 8, is associated with undifferentiated neuroblastoma Apoptosis 2006 11 1 15 24
35. Mohr A., Zwacka R. M., Jarmy G., Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis Oncogene 2005 24 14 2421 2429
36. Fulda S., Kfer M. U., Meyer E., van Valen F., Dockhorn-Dworniczak B., Debatin K.-M., Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer Oncogene 2001 20 41 5865 5877
37. Hopkins-Donaldson S., Ziegler A., Kurtz S., Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines tumors by DNA methylation Cell Death and Differentiation 2003 10 3 356 364
38. Pingoud-Meier C., Lang D., Janss A. J., Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma Clinical Cancer Research 2003 9 17 6401 6409
39. Harada K., Toyooka S., Shivapurkar N., Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines Cancer Research 2002 62 20 5897 5901
40. Cursi S., Rufini A., Stagni V., Src kinase phosphorylates caspase-8 on Tyr380: a novel mechanism of apoptosis suppression The EMBO Journal 2006 25 9 1895 1905
41. Letai A., Bassik M. C., Walensky L. D., Sorcinelli M. D., Weiler S., Korsmeyer S. J., Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2002 2 3 183 192
42. Chen L., Willis S. N., Wei A., Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Molecular Cell 2005 17 3 393 403
43. Willis S. N., Fletcher J. I., Kaufmann T., Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak Science 2007 315 5813 856 859
44. Chen Z. X., Pervaiz S., BCL-2: pro-or anti-oxidant? Frontiers in Bioscience 2009 1 263 268
45. Drge W., Free radicals in the physiological control of cell function Physiological Reviews 2002 82 1 47 95
46. Hockenbery D. M., Oltvai Z. N., Yin X.-M., Milliman C. L., Korsmeyer S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis Cell 1993 75 2 241 251
47. Clment M.-V., Hirpara J. L., Pervaiz S., Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria Cell Death and Differentiation 2003 10 11 1273 1285
48. Schafer Z. T., Kornbluth S., The apoptosome: physiological, developmental, and pathological modes of regulation Developmental Cell 2006 10 5 549 561
49. Borutaite V., Brown G. C., Mitochondrial regulation of caspase activation by cytochrome oxidase and tetramethylphenylenediamine via cytosolic cytochrome c redox state The Journal of Biological Chemistry 2007 282 43 31124 31130
50. Pan Z., Voehringer D. W., Meyn R. E., Analysis of redox regulation of cytochrome c-induced apoptosis in a cell-free system Cell Death and Differentiation 1999 6 7 683 688
51. Suto D., Sato K., Ohba Y., Yoshimura T., Fujii J., Suppression of the pro-apoptotic function of cytochrome c by singlet oxygen via a haem redox state-independent mechanism Biochemical Journal 2005 392 2, part 2 399 406
52. Sturm I., Bosanquet A. G., Radetzki S., Hummel M., Drken B., Daniel P. T., Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation International Journal of Cancer 2006 118 9 2329 2336
53. Soengas M. S., Capodieci P., Polsky D., Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Nature 2001 409 6817 207 211
54. Fu W.-N., Bertoni F., Kelsey S. M., Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia Oncogene 2003 22 3 451 455
55. Wang H.-L., Bai H., Li Y., Sun J., Wang X.-Q., Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer World Journal of Gastroenterology 2007 13 38 5060 5064
56. Watanabe T., Hirota Y., Arakawa Y., Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma Brain Pathology 2003 13 4 431 439
57. Fulda S., Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy Anti-Cancer Agents in Medicinal Chemistry 2008 8 5 533 539
58. Shiozaki E. N., Shi Y., Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology Trends in Biochemical Sciences 2004 29 9 486 494
59. Eckelman B. P., Salvesen G. S., Scott F. L., Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family The EMBO Reports 2006 7 10 988 994
60. Lewis S. M., Holcik M., IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress Cell Death and Differentiation 2005 12 6 547 553
61. Saelens X., Kalai M., Vandenabeele P., Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2- phosphorylation The Journal of Biological Chemistry 2001 276 45 41620 41628
62. Kapp L. D., Lorsch J. R., The molecular mechanics of eukaryotic translation Annual Review of Biochemistry 2004 73 657 704
63. Holcik M., Yeh C., Korneluk R. G., Chow T., Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death Oncogene 2000 19 36 4174 4177
64. Holcik M., Lefebvre C., Yeh C., Chow T., Korneluk R. G., A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection Nature Cell Biology 1999 1 3 190 192
65. Warnakulasuriyarachchi D., Cerquozzi S., Cheung H. H., Holck M., Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element The Journal of Biological Chemistry 2004 279 17 17148 17157
66. Van Eden M. E., Byrd M. P., Sherrill K. W., Lloyd R. E., Translation of cellular inhibitor of apoptosis protein 1 (c-IAP1) mRNA is IRES mediated and regulated during cell stress RNA 2004 10 3 469 481